Connection

Silvio Danese to Interleukin-23

This is a "connection" page, showing publications Silvio Danese has written about Interleukin-23.
Connection Strength

0.895
  1. IL-23 Blockade for Crohn s disease: next generation of anti-cytokine therapy. Expert Rev Clin Immunol. 2017 05; 13(5):457-467.
    View in: PubMed
    Score: 0.643
  2. Positioning Ustekinumab in Crohn's Disease: From Clinical Evidence to Clinical Practice. J Crohns Colitis. 2017 Oct 01; 11(10):1258-1266.
    View in: PubMed
    Score: 0.169
  3. The Expanding Therapeutic Armamentarium for Inflammatory Bowel Disease: How to Choose the Right Drug[s] for Our Patients? J Crohns Colitis. 2018 Jan 05; 12(1):105-119.
    View in: PubMed
    Score: 0.043
  4. Efficacy and Safety of MEDI2070, an Antibody Against Interleukin 23, in Patients With Moderate to Severe Crohn's Disease: A Phase 2a Study. Gastroenterology. 2017 Jul; 153(1):77-86.e6.
    View in: PubMed
    Score: 0.041
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.